Norsk Vaksinefabrikk is commissioning and deploying in Sandefjord the most advanced vaccine fill-finish manufacturing system in Norway.
The Norsk Vaksinefabrikk fill-finish production line is capable of 36,000 2R vials per hour.
In a 10R vial, at 0.5ml per dose, Norsk Vaksinefabrikk capacity is planned to be up to 289,000,000 vaccine doses per month, representing an emergency pandemic preparedness priority fill-finish capacity of up to 5 million vaccine doses in less than 24 hours from delivery of bulk vaccine supply.
Norsk Vaksinefabrikk by Norvax AS is a social enterprise located in Borgeskogen industrial park, Sandefjord, 12 minutes from TORP international airport, for rapid global access.
Norvax focus is on long-term sustained growth and business development in the international biopharmaceutical industry. The Norvax growth plan will create high value employment opportunities in Vestfold og Telemark, Sandefjord, Tønsberg, and Norway.